The Ensign Group, Inc. reported second quarter 2026 financial results for the period ended June 30, 2026. The company reported GAAP diluted earnings per share of $1.68 and adjusted diluted earnings per share of $1.92, representing increases of 16.7% and 20.8% respectively over the prior year quarter. Consolidated revenue rose 17.3% year-over-year to $1.44 billion. Due to strong performance, the company raised its 2026 annual earnings guidance to a range of $7.75 to $7.85 per diluted share and increased annual revenue guidance to $5.87 billion to $5.92 billion. The company also announced a quarterly cash dividend of $0.065 per share. The Ensign Group provides post-acute healthcare services, primarily in skilled nursing and senior living facilities.

The Ensign Group, Inc. Board of Directors approved a $60 million increase to its existing $40 million stock repurchase program, increasing the total authorized capacity to $100 million. The Company may conduct repurchases through open market or privately negotiated transactions. The Ensign Group, Inc. provides post-acute healthcare services.

The Ensign Group, Inc. Board of Directors approved a new $40,000,000 stock repurchase program on May 13, 2026. This program will begin after the current repurchase program expires and allows for open market or privately negotiated transactions. The Ensign Group, Inc. provides post-acute healthcare services.